The Fraunhofer Institute for Cell Therapy and Immunology IZI investigates and develops solutions to specific problems at the interfaces of medicine, life sciences and engineering.

The Institute develops, optimizes and validates methods and products for the Business Units Drugs, Cell Therapy, Diagnostics and Biobanks.

Our competencies include biomarkers, antibodies / ligands, stem cell technology and imaging as well as therapeutic and diagnostic model systems (in vitro / in vivo). Another emphasis is on quality management according to GLP and GMP and on our several years of experience in the operation of clean room facilities.

To our clients and partners from the pharmaceutical, biotechnological and medical technology industry, diagnostic laboratories, clinical units and research facilities we offer complete solutions ranging from market studies right down to the development of a market-ready product and its marketing authorization.